Vaxcyte, Inc. (PCVX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
PCVX currently has 140M outstanding shares. with limited dilution risk as only 11.2M additional shares (8.0%) are authorized for issuance. The company has diluted shareholders by 19.52% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 06, 2026 |
10-Q filing | 139.5M shares outstanding |
140M | 11M |
| Nov 04, 2025 |
10-Q filing | 136.2M shares outstanding |
140M | 11M |
| Aug 06, 2025 |
10-Q filing | 136.0M shares outstanding |
140M | 11M |
| May 07, 2025 |
10-Q filing | 135.7M shares outstanding |
140M | 11M |
| Feb 25, 2025 |
10-K filing | 122.0M shares outstanding |
120M | 11M |
| Nov 05, 2024 |
10-Q filing | 123.7M shares outstanding |
120M | 11M |
| Aug 06, 2024 |
10-Q filing | 117.3M shares outstanding |
120M | 11M |
| May 08, 2024 |
10-Q filing | 111.7M shares outstanding |
110M | 11M |
| Feb 27, 2024 |
10-K filing | 108.4M shares outstanding |
110M | 11M |
| Nov 06, 2023 |
10-Q filing | 101.7M shares outstanding |
100M | 11M |
| Aug 08, 2023 |
10-Q filing | 98.1M shares outstanding |
98M | 11M |
| May 08, 2023 |
10-Q filing | 86.2M shares outstanding |
86M | 11M |
| Feb 27, 2023 |
10-K filing | 80.0M shares outstanding |
80M | 11M |
| Nov 07, 2022 |
10-Q filing | 79.0M shares outstanding |
79M | 11M |
| Aug 08, 2022 |
10-Q filing | 60.8M shares outstanding |
61M | 11M |
| May 09, 2022 |
10-Q filing | 58.3M shares outstanding |
58M | 11M |
| Feb 28, 2022 |
10-K filing | 56.3M shares outstanding |
56M | 11M |
| Nov 10, 2021 |
10-Q filing | 52.8M shares outstanding |
53M | 11M |
| Aug 11, 2021 |
10-Q filing | 52.2M shares outstanding |
52M | 11M |
| May 11, 2021 |
10-Q filing | 51.4M shares outstanding |
51M | 11M |
| Mar 29, 2021 |
10-K filing | 51.3M shares outstanding |
51M | 11M |
| Nov 12, 2020 |
10-Q filing | 50.9M shares outstanding |
51M | 11M |
| Aug 12, 2020 |
10-Q filing | 50.9M shares outstanding |
51M | 11M |
| May 22, 2020 |
S-1 filing: This is an S-1 filing, detailing prior unregistered sales of securities, including common stock options, common stock from option exercises, warrants for preferred stock, and sales of Series B, C, and D convertible preferred stock to accredited investors. |
N/A | 11M |